Today: 20 March 2026
Palo Alto Networks stock slips after Klarich flags share sale; PANW traders eye next catalyst
9 January 2026
1 min read

Palo Alto Networks stock slips after Klarich flags share sale; PANW traders eye next catalyst

New York, January 9, 2026, 15:14 ET — Regular session

  • PANW shares were down about 0.8% in afternoon trade, lagging a broader market rise
  • A new SEC Form 144 disclosed a planned sale by officer Lee Klarich under a 10b5-1 plan
  • Focus shifts to the next earnings update and any read-through on big pending deals

Palo Alto Networks shares slipped on Friday, underperforming a broader tech-led rise, after a late-day regulatory filing flagged a planned insider sale. The stock was down $1.52, or 0.8%, at $189.28, after trading between $187.42 and $192.13.

A Form 144 filed with the U.S. Securities and Exchange Commission showed Lee Klarich, listed as an officer of the company, intends to sell 120,768 class A shares through Goldman Sachs with an aggregate market value of about $23 million. The filing said the sale is tied to a Rule 10b5-1 plan adopted on Sept. 27, 2024 — a pre-set trading program designed to reduce the risk of trading on non-public information — and it represents roughly 0.02% of Palo Alto’s 697 million shares outstanding. StreetInsider.com

The disclosure landed after a choppy week for the stock: Palo Alto jumped 4.3% on Wednesday and fell 1.6% on Thursday, giving back part of that move. The S&P 500 and Nasdaq-tracking ETFs were higher on Friday, leaving PANW’s drop looking more stock-specific than macro. MarketWatch

Cybersecurity shares have been mixed. CrowdStrike was up about 1.5% even after it announced a deal for identity security firm SGNL, while Zscaler fell about 1.5% and Check Point and Fortinet rose modestly. Investors

Palo Alto has pushed investors to focus on subscription-driven growth and cash generation as it broadens its product suite. In November, it raised its fiscal 2026 revenue and adjusted profit forecasts when it announced the $3.35 billion purchase of cloud monitoring firm Chronosphere, with that deal — and its previously announced CyberArk acquisition — expected to close in the second half of its fiscal year. Reuters

That backdrop makes timing awkward. An insider sale, even under a 10b5-1 plan, can still add supply just as investors look for clean follow-through on billings and annual recurring revenue, or ARR — the contracted revenue a company expects to repeat each year.

But the stock has its own traps. Any sign that big customers are stretching purchase decisions, or that integration costs from pending deals run hotter than expected, could squeeze margins and keep a lid on the valuation.

For now, the Form 144 is only a notice of intent. It does not guarantee the shares will be sold, and traders will watch for the actual transactions to show up in later insider-trading disclosures.

The next major test is the company’s fiscal second-quarter results, which Yahoo Finance’s earnings calendar lists for Feb. 12 after the close; Palo Alto has yet to confirm a date. Guidance and an update on deal timing will likely matter more than the size of any one planned sale. Yahoo Finance

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Valero (VLO) stock slides as Venezuela oil talks loom and an analyst trims a target
Previous Story

Valero (VLO) stock slides as Venezuela oil talks loom and an analyst trims a target

Twilio (TWLO) stock slides as CEO share-sale filing lands; February earnings loom
Next Story

Twilio (TWLO) stock slides as CEO share-sale filing lands; February earnings loom

Go toTop